These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20077523)

  • 41. A risk assessment framework for assessing metallic nanomaterials of environmental concern: aquatic exposure and behavior.
    O'Brien NJ; Cummins EJ
    Risk Anal; 2011 May; 31(5):706-26. PubMed ID: 21155861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.
    Bergamaschi E; Bussolati O; Magrini A; Bottini M; Migliore L; Bellucci S; Iavicoli I; Bergamaschi A
    Int J Immunopathol Pharmacol; 2006; 19(4 Suppl):3-10. PubMed ID: 17291399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Occupational hygiene and hygienic regulations during the manufacture, use and utilization of nanomaterials].
    Baranov VI; Sopova EA; Zemlianoĭ PV
    Gig Sanit; 2009; (6):53-5. PubMed ID: 20143490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nano risk analysis: advancing the science for nanomaterials risk management.
    Shatkin JA; Abbott LC; Bradley AE; Canady RA; Guidotti T; Kulinowski KM; Löfstedt RE; Louis G; MacDonell M; Maynard AD; Paoli G; Sheremeta L; Walker N; White R; Williams R
    Risk Anal; 2010 Nov; 30(11):1680-7. PubMed ID: 20846172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An examination of ecological risk assessment and management practices.
    Hope BK
    Environ Int; 2006 Dec; 32(8):983-95. PubMed ID: 16843527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential environmental impact of engineered nanomaterials.
    Colvin VL
    Nat Biotechnol; 2003 Oct; 21(10):1166-70. PubMed ID: 14520401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanotechnology: are occupational health nurses ready?
    McCauley LA; McCauley RD
    AAOHN J; 2005 Dec; 53(12):517-21. PubMed ID: 16401058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles: their potential toxicity, waste and environmental management.
    Bystrzejewska-Piotrowska G; Golimowski J; Urban PL
    Waste Manag; 2009 Sep; 29(9):2587-95. PubMed ID: 19427190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotechnology safety concerns revisited.
    Stern ST; McNeil SE
    Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technology: Nanomaterials need flexible regulation.
    Wickson F
    Nature; 2011 Aug; 476(7360):283. PubMed ID: 21850092
    [No Abstract]   [Full Text] [Related]  

  • 53. Health risk assessment research: implications for synthetic vitreous fibers.
    Paxman D
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 2):S169-81. PubMed ID: 7724847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Critical considerations in evaluating scientific evidence of health effects of ambient ozone: a conference report.
    McClellan RO; Frampton MW; Koutrakis P; McDonnell WF; Moolgavkar S; North DW; Smith AE; Smith RL; Utell MJ
    Inhal Toxicol; 2009 Sep; 21 Suppl 2():1-36. PubMed ID: 19731972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomaterial risk assessment and management experiences related to worker health under the Toxic Substances Control Act.
    Sayre P; Prothero S; Alwood J
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S98-102. PubMed ID: 21654427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Research and regulation of proliferating nanomaterials.
    Furlow B
    Lancet Respir Med; 2013 Jun; 1(4):287. PubMed ID: 24429147
    [No Abstract]   [Full Text] [Related]  

  • 57. Nanomaterial health effects part 3: conclusion--hazardous issues and the precautionary principle.
    Kanarek MS
    WMJ; 2007 Feb; 106(1):16-9. PubMed ID: 17393752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward.
    Landsiedel R; Ma-Hock L; Haussmann HJ; van Ravenzwaay B; Kayser M; Wiench K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):399-413. PubMed ID: 22639437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A brief review of the occurrence, use, and safety of food-related nanomaterials.
    Magnuson BA; Jonaitis TS; Card JW
    J Food Sci; 2011 Aug; 76(6):R126-33. PubMed ID: 22417518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.